✉news HealthHealth first seen 7 h ago, last 4 h ago, peak #12
WHO backs lifestyle changes over GLP-1 drugs for child obesity
Original: WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight
The World Health Organization has endorsed lifestyle changes as the primary approach to tackling childhood obesity, positioning them ahead of GLP-1 weight-loss drugs such as those making headlines worldwide. According to Reuters, the guidance signals caution about relying on medication for children, favoring diet, exercise and behavioral support as the first line of response to rising obesity rates.
Why now: The guidance arrives amid surging global interest and demand for GLP-1 weight-loss drugs, making the WHO's cautious stance on their use in children a talking point.
World Health OrganizationGLP-1 drugsReuters
Rank over time, top of the chart is #1. 4 snapshots from 7 h ago to 4 h ago.
Evidence
- WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight · Reuters
- WHO Endorses Lifestyle Changes Over GLP-1 Drugs in Child Obesity Fight · U.S. News & World Report
API: https://socialmediatrends-api.osmike.com/v1/trends/1337849